Share Twitter LinkedIn Facebook Email Hope Rugo, M.D., University Of California San Francisco discusses EMBRACA Trial, FDA Approval Of Talazoparib. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer Breast 4 Mins Read